Medical Management and Device-Based Therapies in Chronic Heart Failure

Area of Science:

• Cardiology
• Medical Devices

Background:

• Heart failure (HF) is a leading cause of global morbidity and mortality.
• Current guideline-directed medical therapy (GDMT) offers advancements for HF with reduced ejection fraction (HFrEF) and HF with preserved ejection fraction (HFpEF).

Purpose of the Study:

• To review the current landscape of GDMT for chronic HF.
• To discuss limitations and barriers to GDMT implementation.
• To summarize device-based therapies for HF management.

Main Methods:

• Literature review of guideline-directed medical therapy for chronic heart failure.
• Analysis of limitations in medical therapy implementation and adherence.
• Review of established and emerging device-based interventions for all HF phenotypes.

Main Results:

• Despite medical advancements, significant barriers to GDMT implementation exist, including delays, tolerability, and cost.
• A substantial number of patients remain symptomatic with poor outcomes.
• Device-based interventions show promise and established efficacy across HF phenotypes.

Conclusions:

• Unmet clinical needs in HF management persist despite optimal medical therapy.
• Device-based therapies represent a growing and important area for improving outcomes in chronic heart failure.
• A comprehensive approach integrating medical and device therapies is crucial for effective HF management.